KRAS and colorectal carcinoma: Interestingly, however, in a recent CRC study, Fiala et al. demonstrated that G12V and G12A mutation were predictors of shorter PFS and OS, while patients with tumors harboring other KRAS mutations had a similar outcome to those with KRAS WT tumors [27].